Author

Mary-Helen Barcellos-Hoff

University of California, San Francisco

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Alessandro ScapozzaiD· 1 shared Camila D. Arcuschin· 1 shared Carolina Di BenedettoiD· 1 shared Cecilia Schwarzer· 1 shared Denise P. MuñoziD· 1 shared Dietmar J. KappesiD· 1 shared Ignacio E. SchoriD· 1 shared Jean‐Philippe CoppéiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alessandro ScapozzaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4+ cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotype

Camila D. Arcuschin, Kamin Kahrizi, Rosalyn W. Sayaman, Carolina Di Benedetto, Pedro J Salaberry, Roxana Pirker, Yizhuo Shen, Ons Zakraoui, Cecilia Schwarzer, Alessandro Scapozza, Joseph A. Caruso, Paola A. Betancur, Julie Deane Saba, Jean‐Philippe Coppé, Mary-Helen Barcellos-Hoff, , Denise P. Muñoz

The paper identifies ThPOK/ZBTB7B as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotype by suppressing metastatic pathways.

Cellular and Molecular Life Sciences · Nov 13, 2025Peer-reviewedCancer Biology